Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 8,760.00
+40.00 (0.46%)
Jul 21, 2026, 2:50 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 806.62 billion as of July 20, 2026. Its market cap has decreased by -12.63% in one year.
Market Cap
806.62B
Enterprise Value
1.83T
Revenue
1.29T
Ranking
n/a
PE Ratio
n/a
Stock Price
8,760.00
ChartMarket Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 806.62B, an increase of 141.41%. That is a compound annual growth rate of 5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 806.62B | -27.94% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voronoi | 2.62T |
| Hugel | 2.59T |
| Orum Therapeutics | 986.07B |
| Pharmicell | 665.30B |
| Onconic Therapeutics | 658.41B |
| GI Innovation | 472.26B |
| Medy-Tox | 466.66B |
| GC Corp. | 437.22B |